Bharat Parenteral News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bharat parenteral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bharat Parenteral Today - Breaking & Trending Today

Share Market Highlights 13 March 2024: Sensex sheds 906 pts, Nifty slips below 22k amidst turmoil in small-, mid-cap segments

Share Market Highlights 13 March 2024: Sensex sheds 906 pts, Nifty slips below 22k amidst turmoil in small-, mid-cap segments
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

United States , Saudi Arabia , Andhra Pradesh , United Kingdom , West Bengal , Jammu And Kashmir , United Arab Emirates , Anil Yadav , Amit Kumar Singh , Vikas Jain , Auro Pharma , Jagdish Kumar Arora , Aurobindo Pharma , Prashanth Tapse , Deepak Jasani , Adani Wilmar , Rungta Greentech , Innoxel Lifesciences , Vaishali Parekh , Kunal Virenchee Sagar , Mukund Kabra , Glenmark Pharma , Manoj Gupta , Zydus Lifescience , Laxmi Devi , Akshays Pitti ,

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us
25/05/2021
Representative photo: analuisa gamboa/Unsplash
Mumbai: Since the start of the COVID-19 pandemic last year, researchers around the world have evaluated scores of drugs and therapeutic techniques for the disease. Even according to the Clinical Trial Registry of India (CTRI), researchers in the country are testing everything from inhaled camphor and ajwain to Viagra.
This may be desperation, given the brutality of India’s second COVID-19 outbreak. It is also worthwhile in more ways than one to repurpose existing drugs to treat COVID-19.
However, in most cases, a substantial profit motive isn’t too far away. Together with India’s opaque drug regulation apparatus and its propensity to approve substances on little to no evidence – especially during the pandemic itself – these clinical trials warrant a closer look. ....

United Kingdom , Czech Republic , Silver Spring , United States , Nossa Senhora Da Conceicao , Junshi Bioscience , Macleod Pharma , Gufic Bioscience , Zydus Cadila Virafin , Swati Spentose , Eli Lilly , Neil Brandvold Dndi Wikimedia Commons , Porto Alegre , Inosine Pranobex , Murali Neelakantan , Shenyang Tonglian Group , Institute Of Medical Sciences , Central Drug Standards Control Organisation , Drug Administration , Indian Council Of Medical Research , Navin Saxena Research , Expert Committee , Clinical Trial Registry , All Institute , Medical Sciences , Indian Council ,